Medical News

Surgery

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

In H et al. - This is the first formal cost-effectiveness study in the US of the optimal treatment for patients with Graves disease who fail to achieve euthyroidism after 18 months of ATM. The findings demonstrate that TT is more cost effective than RAI or lifelong ATM in these patients; this continues until the cost of TT becomes > $19,300.

Related Articles

Graves' Disease Associated with Primary Systemic Sclerosis
Orbit - The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery, 11/12/09    Relevance Score: 68%

Premature hair greying may predict reduced bone mineral density in Graves' disease
Irish Journal of Medical Science, 10/27/09    Relevance Score: 68%

Thyroidectomy in Graves' Disease: Subtotal, Near Total or Total
Orbit - The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery, 11/09/09    Relevance Score: 67%

Update on thyroid eye disease and management
Clinical Ophthalmology, 10/19/09    Relevance Score: 67%

Treatment for Graves' Disease Poses Risk of Liver Failure
American Journal of Nursing, 10/01/09    Relevance Score: 67%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address